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Abstract
Dengue is a mosquito-borne disease caused by one of four serotypes of Dengue virus (DENV-1–4). Severe dengue infection
in humans is characterized by thrombocytopenia, increased vascular permeability, hemorrhage and shock. However, there is
little information about host response to DENV infection. Here, mechanisms accounting for IFN-c production and effector
function during dengue disease were investigated in a murine model of DENV-2 infection. IFN-c expression was greatly
increased after infection of mice and its production was preceded by increase in IL-12 and IL-18 levels. In IFN-c
2/2 mice,
DENV-2-associated lethality, viral loads, thrombocytopenia, hemoconcentration, and liver injury were enhanced, when
compared with wild type-infected mice. IL-12p40
2/2 and IL-18
2/2 infected-mice showed decreased IFN-c production,
which was accompanied by increased disease severity, higher viral loads and enhanced lethality. Blockade of IL-18 in
infected IL-12p40
2/2 mice resulted in complete inhibition of IFN-c production, greater DENV-2 replication, and enhanced
disease manifestation, resembling the response seen in DENV-2-infected IFN-c
2/2 mice. Reduced IFN-c production was
associated with diminished Nitric Oxide-synthase 2 (NOS2) expression and NOS2
2/2 mice had elevated lethality, more
severe disease evolution and increased viral load after DENV-2 infection. Therefore, IL-12/IL-18-induced IFN-c production
and consequent NOS2 induction are of major importance to host resistance against DENV infection.
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Introduction
Dengue fever (DF) and its severe forms, dengue hemorrhagic
fever (DHF) and dengue shock syndrome (DSS), are mosquito-
borne diseases caused by one of four serotypes of Dengue virus
(DENV-1–4). Fifty to 100 million cases of DF are estimated
annually mostly in tropical and subtropical regions of the world [1–
3]. According to the World Health Organization (WHO), around
500,000 patients develop the severe forms of dengue and 20,000
deaths are estimated to occur each year. DHF is defined by the
WHO as fever with hemorrhagic manifestations, thrombocytope-
nia, and hemoconcentration or other signs of plasma leakage [2].
Treatment of DF and of the severe forms of dengue infection is
largely supportive. The large number of infected individuals, the
lack of clinical or laboratory markers that indicate which patients
will develop severe disease and the lack of specific treatment place
an enormous burden on health systems of low income countries [2].
The pathogenesis of DENV infection remains poorly under-
stood and involves a complex interplay of viral and host factors.
Risk factors for severe disease include age [1,4], viral serotype
[1,5] and genotype [1,6,7], and the genetic background of the host
[1,8], among others. Retrospective and prospective human studies
have demonstrated that secondary infection by a heterologous
serotype is the single greatest risk factor for DHF/DSS [9–11].
However, severe disease may also occur after primary infection
[5,12,13]. In both cases, there appears to be a correlation between
disease severity and viral load [9–13]. In addition, the immuno-
pathogenesis of DENV probably involves the effects of cytokines
on both infected and bystander immune cells, hepatocytes, and
endothelial cells [2,3,13]. There are several studies which show
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role of IFN-c in clinical dengue is somewhat controversial [14–16].
There are studies which suggest that levels of this cytokine may
correlate positively with disease in humans [16], but other studies
have shown that increased IFN-c production correlated with higher
survival rates in DHF patients [15]. In experimental systems, non-
adapted viruses usually are unable to reach high viral loads, except
in mice deficient for IFN receptors, suggesting that IFN-c and its
receptors are necessary for host resistance to Dengue infection [17–
19]. However, the major cell types producing IFN-c, mediators
controlling production of this cytokine and major effector
mechanisms triggered by IFN-c are not known.
Optimal IFN-c production in various infections models in mice
is controlled by cytokines, especially IL-12 and IL-18 [20,21]. The
IFN-c produced may then upregulate inducible nitric oxide
synthase (NOS2), resulting in high levels of NO production by
dendritic cells and macrophages [22]. NO is known to possess
potent antiviral activities [22]. Therefore, in order to examine the
role played by these molecules during dengue disease we
conducted infection experiments in mice infected with an adapted
strain of DENV-2. This unique DENV-2 strain was chosen
because it was previously shown to induce in immunocompetent
mice a disease that resembles severe dengue cases in humans [23–
25], what does not happen with most non-adapted strains usually
utilized in experimental settings [2,3]. We show that disease is
more severe and there are higher viral loads after DENV-2
infection of IFN-c-deficient mice. Furthermore, we demonstrate
that the combined action of IL-12 and IL-18 is necessary for
optimal IFN-c production and control of DENV-2 infection.
Finally, we show that IFN-c controls expression of NOS2 and NO
production after DENV-2 infection and that NO production is
crucial for resistance of the murine host to infection with DENV.
Methods
Ethics Statement
This study was carried out in strict accordance with the Brazilian
Government’s ethical and animal experiments regulations. The
experimental protocol was approved by the Committee on the
EthicsofAnimalExperimentsoftheUniversidadeFederaldeMinas
Gerais (CETEA/UFMG, Permit Protocol Number 113/09). All
surgery was performed under ketamine/xylazine anesthesia, and all
efforts were made to minimize suffering. The guidelines followed by
this Committee are based on the guidelines of Animal Welfare Act
(AWA) and associated Animal Welfare Regulations (AWRs) and
Public Health Service (PHS) Policy.
Animals
Mice deficient for IFN-c and NOS-2 were obtained from The
Jackson Laboratory and were bred and maintained at the
Gnotobiology and Immunology Laboratory of Instituto de
Cie ˆncias Biolo ´gicas. Mice deficient for IL-12p40 were kindly
provided by Dr. J. Magran through Dr. L. V. Rizzo (Instituto de
Cie ˆncias Biome ´dicas (ICB), University of Sa ˜o Paulo, Sa ˜o Paulo,
Brazil) and were bred and maintained at the Gnotobiology and
Immunology Laboratory of Instituto de Cie ˆncias Biolo ´gicas. Mice
deficient for IL-18 [26] were kindly provided by Dr. F.Q. Cunha
and were bred and maintained at the Gnotobiology and
Immunology Laboratory of Instituto de Cie ˆncias Biolo ´gicas. Mice
deficient for IL-23p19 [27] were bred and maintained at the
animal facility of the Transgenose Institute (CNRS, Orleans). All
mice were on C57BL/6J genetic background (back-crossed at least
10 times) and wild-type control C57BL/6J (WT) mice were used,
except for IL-18-deficient mice, that were on the BALB/c
background and were compared to their proper WT littermates.
For experiments, 7–10 weeks old mice were kept under specific
pathogen–free conditions, in filtered-cages with autoclaved food
and water available ad libitum.
Virus
An adapted Dengue virus 2 (DENV-2) strain was obtained from
the State Collection of Viruses, Moscow, Russia [23]. Briefly, the
virus had undergone two passages in the brain of BALB/c suckling
mice. Five days after infection, brains of moribund mice were
harvested for preparing 10% (w/v) brain suspension in modified
Eagle’s medium (MEM). After that, eight sequential passages
through BALB/c mice of different ages (1–4 weeks old) by
intraperitoneal (i.p.) injection were performed. Two sequential
passages were carried out for each age group of. After each
passage, the brains of the moribund mice were harvested for
preparing 10% brain suspension and then used for the next
passage. The last passage of DENV-2 strain P23085 was
performed in neonatal mice to produce stocks which were stored
as 10% brain suspension at 270uC. Sequences of portions of E
and NS1 genes of the adapted virus were deposited previously at
GenBank under the accession number AY927231 [22]. Virus
adaptation was performed in a biosafety level-3 (BSL-3) facility of
the SRC VB «Vector», Russia, Koltsovo. After adaptation,
monolayers of Aedes albopictus C6/36 cell line were infected with
DENV-2 strain P23085 at a multiplicity of infection (MOI) of
0.05 PFU/cell and incubated at 28uC for 5–7 days. The cultured
medium was harvested after cytopathic effect was noticed and cell
debris removed by centrifugation. The virus supernatant was
collected and stored at 270uC until use. The cultured medium of
mock-infected monolayers of Aedes albopictus C6/36 cell line was
used as control of the infection. To calculate virus titer, expressed
as LD50, in the harvested cultured medium, groups of ten mice
were inoculated i.p. with serial dilutions of the virus and lethality
recorded. The titer of our DENV-2 stock was 10
5 LD50/ml of
suspension, as calculated in 8–10-week-old BALB/c mice. 1LD50
corresponded to 20 PFU of the adapted DENV-2 strain.
Author Summary
Dengue fever and its severe forms, dengue hemorrhagic
fever and dengue shock syndrome, are the most prevalent
mosquito-borne diseases on Earth. It is caused by one of
four serotypes of Dengue virus (DENV-1–4). At present,
there are no vaccines or specific therapies for dengue and
treatment is supportive. Host response to infection is also
poorly understood. Here, using a DENV-2 strain that causes
a disease that resembles the severe manifestations of
Dengue in humans, we demonstrate that IFN-c production
is essential for the host to deal with infection. We have also
shown that IFN-c production during DENV infection is
controlled by the cytokines IL-12 and IL-18. Finally, we
show that one of the mechanisms triggered by IFN-c
during host response to DENV infection is the production
of Nitric Oxide, an important virustatic metabolite. Mice
deficient for each of these molecules present marked
increase in DENV replication after infection and more
severe disease. Altogether, this study demonstrates that
the IL-12/IL-18-IFN-c-NO axis plays a major role in host
ability to deal with primary DENV infection. These data
bear relevance to the understanding of antiviral immune
responses during Dengue disease and may aid in the
rational design of vaccines against DENV infection.
IFN-c and Dengue Infection
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For infection experiments, the virus-containing cell-supernatant
was diluted in endotoxin-free PBS and injected i.p. into mice. For
the evaluation of lethality, mice were inoculated i.p. with DENV-2
virus and lethality rates evaluated every 12 h. The various other
parameters were evaluated at 3, 5 or 7 days after i.p. inoculation of
the virus. In all experiments using genetically deficient mice,
experiments with the relevant WT controls were performed in
parallel. Non-infected (NI) animals were inoculated with suspen-
sion from non-infected cell supernatant diluted in a similar
manner. In the experiments involving genetically deficient mice,
the NI group represents the pooled results obtained from the
analysis of deficient mice and WT non-infected mice. Results were
pooled for ease of presentation.
In some experiments IL-18 was neutralized by daily i.p.
injection of 250 mg of recombinant human IL-18BP per animal
(hIL-18 bp), starting 1 hour after DENV-2 inoculation until day 4
after virus inoculation. The dose was chosen based in a previous
study [28]. Control animals received PBS. The hIL-18 bp isoform
was a kind gift of Dr. Amanda Proudfoot from Merck-Serono
Pharmaceuticals (Geneve, Switzerland).
Cell culture and in vitro infection studies
Murine bone marrow cells were isolated from femurs and were
differentiated into myeloid DCs after culturing at 2610
6 cells/ml
for 10 days in RPMI supplemented with 10% FBS and 4% J558L
cell-conditioned medium as a source of GM-CSF as described
[29]. DCs were plated in 96-well microculture plates (at 2610
5
cells/well in DMEM supplemented with 2 mM L-glutamine and
2610
25 M 2-ME) and for infection, cells were incubated with
50 mL of the cell supernatant suspension containing DENV-2 at
0,01 MOI in the presence or not of recombinant murine IFN-c
(100 U/ml). Negative controls were stimulated with sterile cell
supernatant obtained from mock infected cells.
Titration of virus
Mice were assayed for viral titers in spleen. For virus recovery in
spleen, the organ was collected aseptically and stored at 270uC
until assayed for DENV-2 virus. Tissue samples were weighed,
grounded by using a pestle and mortar and prepared as 10% (w/v)
homogenates in minimal essential medium (MEM) without fetal
bovine serum (FBS). Viral load in the supernatants of tissue
homogenates assessed by direct plaque assays using LLC-MK2
cells cultured in agarose overlay. Briefly, organ homogenates were
diluted serially and a 0.4 ml volume placed in duplicate into each
of 6-wells of LLC-MK2 cell monolayers and incubated for 1 h. An
overlay solution containing 26 MEM and 1% agarose in equal
volumes was added to each well and the cultures incubated for 7
days. Cultures were stained with crystal violet for enumeration of
viral plaques. Cell monolayers incubated with tissue homogenates
of not infected mice were used as control for the assay. The results
were measured as plaque forming units (PFU) per gram of tissue
weight. The limit of detection of the assay was 100 PFU/g of
tissue.
Measurement of cytokine/chemokine concentrations
The concentration of cytokines (TNF-a, IFN-c, IL-6, IL-12p40,
IL-12p70 and IL-18) in serum or tissue samples was measured
using commercially available antibodies and according to the
procedures supplied by the manufacturer (R&D Systems,
Minneapolis, except for IL-18, manufactured by BD Pharmingen).
Serum was obtained from coagulated blood (15 min at 37u, then
30 min a 4uC) and stored at 220uC until further analysis. One
hundred milligrams of tissues (liver and spleen) was homogenized
in 1 ml of PBS containing anti-proteases (0.1 mM phenylmethil-
sulfonyl fluoride, 0.1 mM benzethonium chloride, 10 mM EDTA
and 20 KI aprotinin A) and 0.05% Tween 20. The samples were
then centrifuged for 10 min at 3000 g and the supernatant
immediately used for ELISA assays. The detection limit of the
ELISA assays was in the range of 4–8 pg/ml.
Quantification of nitrite in cell supernatants
Cell-free culture medium was obtained by centrifugation and
assayed for nitrite content, determined by the Griess method [30].
For this assay, 0.1 ml of culture medium was mixed with 0.1 ml of
Griess reagent in a multiwell plate, and the absorbance at 550 nm
read 10 min later. The NO2
2 concentration (mM) was determined
by reference to a NaNO2 standard curve.
Evaluation of blood parameters
Blood was obtained from the brachial plexus in heparin-
containing syringes at the indicated times. The final concentration
of heparin was 50 u/ml. Platelets were counted in a Coulter
Counter (S-Plus Jr). Results are presented as number of platelets
per ml of blood. For the determination of the hematocrit, a sample
of blood was collected into heparinized capillary tubes and
centrifuged for 10 min in a Hematocrit centrifuge (HT, Sa ˜o Paulo,
Brazil).
Transaminase activity
Aspartate transaminase activity was measured in individual
serum samples, using a commercially available kit (Bioclin, Belo
Horizonte, Brazil). Results are expressed as the U/dL of serum.
Real Time PCR
Total RNA was isolated from Spleen of mice for evaluation of
NOS2 mRNA expression. RNA isolation was performed using
Illustra RNAspin Mini RNA Isolation Kit (GE Healthcare). The
RNA obtained was resuspended in diethyl pyrocarbonate treated
water and stocked at 270uC until use. Real-time RT-PCR was
performed on an ABI PRISM 7900 sequence-detection system
(Applied Biosystems) by using SYBR Green PCR Master Mix
(Applied Biosystems) after a reverse transcription reaction of 2 mgo f
total RNA by using M-MLV reverse transcriptase (Promega). The
relative level of gene expression was determined by the comparative
threshold cycle method as described by the manufacturer, whereby
data for each sample were normalized to hypoxanthine phosphor-
ibosyltransferase and expressed as a fold change compared with
non-infected controls. The following primer pairs were used:
hypoxanthine phosphoribosyltransferase,5 9-GTTGGTTACAGGCCA-
GACTTTGTTG-39 (forward) and 59-GAGGGTAGGCTGGCC-
TATAGGCT-39 (reverse); and nos2,5 9- CCAAGCCCTCACC-
TACTTCC -39 (forward) and 59- CTCTGAGGGCTGACA-
CAAGG -39 (reverse).
FACS analysis
Spleen cells were evaluated ex vivo for extracellular molecular
expression patterns and for intracellular cytokine expression
patterns. Briefly, spleens were removed from infected mice at
the indicated timepoints. Then cells were isolated, and immedi-
ately stained for surface markers, fixed with 2% formaldehyde and
then permeabilized with a solution of saponin and stained for
30 min at room temperature, using conjugated anti-IFN-c
monoclonal antibodies. Preparations were then analyzed using a
FACScan (Becton Dickinson), and 50 000 gated events on total
lymphocyte/monocyte population were acquired for later analysis.
IFN-c and Dengue Infection
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population analysis in CD4
+ cells. Briefly, lymphocyte/monocyte
population was isolated in gate R1. At this region, the cell
population positive for the surface marker of interest was isolated
(R2) and among cells in this region, IFN-c
+ cells were obtained
(R3). Analogous strategies were utilized for the other several
populations studied. The antibodies used for the staining were rat
immunoglobulin controls, anti-CD4-PE, anti-CD8-PE, anti-
NK1.1-PE, anti-CD3- PE-Cy5 and anti-IFN-c-FITC (all from
Biolegend Inc). Analysis was conducted using the software Flow Jo
7.2 (Tree Star Inc).
Histopathology and immunohistochemestry
A portion of liver was obtained from killed mice at the indicated
time points, immediately fixed in 10% buffered formalin for
24 hours and tissues fragments were embedded in paraffin. Tissue
sections (4 mm thick) were stained with hematoxylin and eosin
(H&E) and examined under light microscopy or collected in serial
sections on glass slides coated with 2% 3-aminopropyltriethylsilane
(Sigma Aldrich, St. Louis, MO). The latter sections were
deparaffinized by immersion in xylene, and this was followed by
immersion in alcohol and then incubation with 3% hydrogen
peroxide diluted in Tris-buffered saline (TBS) (pH 7.4) for
30 minutes. The sections were then immersed in citrate buffer
(pH 6.0) for 20 minutes at 95uC for antigen retrieval. The slides
were then incubated with the rabbit polyclonal anti-NOS2 (N-20,
sc-651, Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:100;
at 4uC overnight in a humidified chamber. After washing in TBS,
the sections were treated with a labeled streptavidin-biotin kit
(LSAB, K0492, Dako, Carpinteria, CA). The sections were then
incubated in 3,39-Diaminobenzidine (K3468, Dako) for 2 to
5 minutes, stained with Mayer’s hematoxylin and covered.
Negative controls were obtained by the omission of primary
antibodies, which were substituted by 1% PBS-BSA.
Statistical analysis
Results are shown as means 6 SEM. Differences were
compared by using analysis of variance (ANOVA) followed by
Student-Newman-Keuls post-hoc analysis. Differences between
lethality curves were calculated using Log rank test (Graph Prism
Software 4.0). Results with a P,0.05 were considered significant.
Results
IFN-c production is necessary for host resistance to DENV
primary infection
An initial set of experiments were carried out to assess the
kinetics of IFN-c production and major IFN-c producing cell types
after DENV-2 infection. As shown in Figure 1, there was an
increase in serum and splenic levels of IFN-c from the 5
th day of
infection (Figure 1A). Levels of IFN-c enhanced further at day 7 in
both serum and spleen (Figure 1A). In spleen, IFN-c staining was
detected in about 10% of total cells in the 5
th day after inoculation
and reached about 15% at the 7
th day post infection (Figure 1B
and Figure S1B). CD3
2NK1.1
+ NK cells and CD3
+NK1.1
+ NKT
populations presented increased proportions of IFN-c staining at
the 5
th day post infection (Figure 1B and Figure S1E and S1F). In
addition, there was increase in expression of IFN-c on all cell
populations analyzed at day 7 after infection (Figure 1B).
Significantly, over 30% of CD4
+ T cells, 25% of CD8
+ T cells,
40% of CD3
2NK1.1
+ NK cells and CD3
+NK1.1
+ NKT cells
were IFN-c
+ at day 7 after infection (Figure 1B and Figures S1C–
F). When the gate was set at IFN-c
+ cells, the majority of IFN-c
+
cells were CD8
+ T cells (3063%) and CD4
+ T cells (2561%).
To investigate the role played by IFN-c during DENV
infection, WT and IFN-c-deficient (IFN-c
2/2) mice were
inoculated DENV-2 and lethality rates and disease course
evaluated. As seen in Figure 1C, 100% of IFN-c
2/2 mice were
dead before the seventh day of infection, and only 15% of WT
mice had succumbed to infection. This early lethality of IFN-c
2/2
mice was characterized by more severe manifestation of disease
after DENV infection. Three days after infection, IFN-c
2/2 mice
already presented reduced platelets counts (Figure 1D), and at the
5
th day of infection, there was marked thrombocytopenia
(Figure 1D) and significant increase in hematocrit values
(Figure 1E) in IFN-c
2/2 mice when compared to WT mice. In
addition to the alterations seen in hematological parameters, there
was enhanced production of pro-inflammatory cytokines after
infection. As shown in Figures 1F and 1G, there were no
detectable levels of TNF-a and IL-6 in serum of WT mice at day 5
after DENV-2 infection. However, both cytokines were signifi-
cantly elevated in serum of infected IFN-c
2/2 mice (Figures 1F
and 1G). Infected-IFN-c
2/2 mice showed hepatic injury, as
assessed by increased AST activity in plasma of IFN-c
2/2 mice in
the 5
th day of infection (Figure 1H). There was also marked
changes in liver architecture. WT mice inoculated with DENV-2
had little changes in liver, as assessed by histology. In contrast,
there were signs of congestion and hepatocyte degeneration and
necrosis in infected IFN-c
2/2 mice (Figure 1I). In addition to the
greater disease severity observed, IFN-c
2/2 mice presented
greater viral replication after infection than in WT mice. At the
3
rd day of infection, IFN-c
2/2 mice presented a 10 fold increase in
DENV-2 viral loads in spleen and DENV-2 titers in spleen of
infected-IFN-c
2/2 mice were above 1.5 log greater than in
infected-WT mice in the 5
th day of infection (Figure 1J).
Therefore, the data depicted here show IFN-c is expressed and
plays an important role in host defense against DENV infection.
IL-12 and IL-18 control IFN-c production during DENV
infection
Our next objective was to evaluate the roles of IL-12 and IL-18
in controlling IFN-c production by the murine host during DENV
infection. After DENV-2 infection, there were detectable levels of
both IL-12p70 and IL-12p40 in the spleen of WT mice already in
the 3
rd day of infection (Figure 2A). The concentration of both
cytokines was increased in the 5
th and remained above
background levels at the 7
th day of infection (Figure 2A). This
early production is consistent with a putative role of IL-12 in
inducing IFN-c production. Consistently with the latter possibility,
there was a drastic reduction in IFN-c production after DENV-2
infection of IL-12p40
2/2 mice, which are deficient for both IL-12
and IL-23 production (Figures 2B and 2C). In keeping with the
relevance of IFN-c during dengue infection and reduced IFN-c
production, there was enhanced lethality rates (Figure 2D),
increased thrombocytopenia (Figure 2E) and enhanced hemocon-
centration (Figure 2F) after DENV-2 infection of IL-12p40
2/2
mice. There were higher concentrations of TNF-a (Figure 2G) and
IL-6 (Figure 2H) in spleen and more severe hepatic injury in IL-
12p40
2/2 than WT mice after infection (Figure 2I and 2J).
Finally, IL-12p40 deficiency resulted in greater loads of DENV-2
in spleen at the 7
th day after infection, when compared with WT-
infected mice (Figure 2K). The reduction of IFN-c production and
the more severe disease seen in IL-12p40
2/2 mice seem to be
specifically due to IL-12 deficiency as IL-23p19
2/2-deficient mice
produced similar amounts of IFN-c after DENV-2 infection
(Supplementary Figure S2A) and presented a disease of similar
intensity (Figure S2B and S2C) and unaltered viral loads (Figure
S2 D) when compared to infected-WT mice.
IFN-c and Dengue Infection
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infections is IL-18 [21]. In the present study, IL-18 concentra-
tions rose rapidly in liver at the 3
rd day of DENV-2 infection, but
returned to basal levels in the subsequent timepoints evaluated
(Figure 3A). There was marked reduction of IFN-c production in
spleen and serum of DENV-2-infected IL-18
2/2 mice when
compared with WT infected mice (Figure 3B and 3C,
respectively). Available IL-18
2/2 mice were in the BALB/c
background which we have previously shown to be more
susceptible to DENV2-induced disease and lethality [24]. Indeed,
all WT mice in the BALB/c background were dead by day 10 of
DENV-2 infection using an inoculum that caused little lethality in
C57Bl/6 mice (compare Figures 3D and 1C). All IL-18
2/2 mice
also succumbed to infection but mice died earlier than WT
controls after DENV-2 infection (p=0.0237) (Figure 3D).
Although the degree of thrombocytopenia was similar in both
strains of mice (Figure 3E), hemoconcentration was greater in IL-
18
2/2 than WT infected mice (Figure 3F). Levels of TNF-a
(Figure 3G) and IL-6 (Figure 3H) and severity of liver injury
(Figure 3I and 3J) occurred to a greater extent in spleens of IL-
18
2/2 than WT infected mice (Figure 3G and 3H). Significantly,
enhanced clinical disease and earlier deaths were accompanied
by elevation in viral loads in spleen of IL-18
2/2 mice
(Figures 3K).
The phenotype of either IL-12
2/2 or IL-18
2/2 mice were not
as severe as the phenotype of IFN-c
2/2 mice. For example,
whereas viral loads were already approximately 2 log greater at
day 5 in IFN-c
2/2 mice, this was not the case in IL-12
2/2 or IL-
18
2/2 mice (Figures 2J and 3J). Indeed, IFN-c production was not
abolished in IL-12
2/2 or IL-18
2/2 mice and viral loads were only
significantly different from WT at day 7 after infection (see
Figures 2J and 3J). In order to block simultaneously the action of
both IL-12 and IL-18, IL-12p40
2/2 mice were treated with IL-
18 bp at doses shown to block IL-18 action [28]. Treatment of IL-
12p40
2/2 mice with IL-18 bp also resulted in total abrogation of
IFN-c levels in serum (Figure 4A) or spleen (Figure 4B) of infected
mice. Treatment of IL-12p40
2/2 with IL-18 bp also resulted in
marked enhancement of viremia already at day 5 after infection
(Figure 4C), results which are similar to those obtained in IFN-c
2/2
mice (Figure 1I) and substantially different from results observed at
day 5 in IL-12p40
2/2 mice or mice treated with IL-18 bp alone
(Figure 4C). Moreover, treatment of IL-12p40
2/2 with IL-18 bp
resulted in thrombocytopenia, which was similar to that observed in
IL-12p40
2/2 or IL-18 bp-treated mice (Figure 4D), and hemo-
concentration, which was greater than in the other groups
(Figure 4E). Levels of IL-6 in plasma were also further enhanced
by the treatment of IL-12p40
2/2 mice with IL-18 bp than in either
condition alone (Figure 4F). The enhanced viral load and greater
Figure 1. IFN-c-deficient mice are highly susceptible to DENV infection. (A) WT mice were inoculated with 10LD50 of DENV-2 and at the
indicated timepoints, the following parameters were assessed: IFN-c concentration in serum (left panel) and spleen (right panel), measured by ELISA
(A); IFN-c intracellular staining in splenic cells, assessed by FACS analysis (B). (C–J) WT and IFN-c
2/2 mice were inoculated with 10LD50 of DENV-2 and
at the indicated timepoints, the following parameters were assessed: lethality rates after infection (C); platelet counts (D) and hematocrit (E) in blood;
TNF-a (F) and IL-6 (G) concentration, measured by ELISA, and AST activity (H), measured by colorimetric assay, in serum; Liver injury, assessed by
Hematoxylin & Eosin staining (five days after infection) (I); Viral loads recovered from the spleen, by plaque assay (J). Results are expressed as mean 6
SEM (except for J, expressed as median) and are representative of at least two independent experiments. N=5 mice per group * P,0.05 vs. NI.
# P,0.05 vs. WT. NI: Not infected. ND: Not detected. dpi:day post-infection.
doi:10.1371/journal.pntd.0001449.g001
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IL-12p40
2/2 mice treated with IL-18 bp than in either condition
alone or WT mice (Lethality rate at day 7: WT mice, 0%; IL-18
bp-treated mice, 0%; IL-12p40
2/2 mice, 33%; IL-12p40
2/2
mice+IL-18 bp, 83%, n=6). In concert, the data presented above
suggest that IL-12 and IL-18 act together to induce optimal IFN-c
production during dengue infection in mice.
IFN-c-mediated protection to DENV infection involves
elevation of NOS2-mediated NO production
Nitric Oxide production by phagocytes is a well known effector
mechanism induced by IFN-c during host response to infections
[22]. To assess whether this pathway is relevant in host response to
DENV infection, we evaluated NOS2 expression after DENV-2
infection. As shown in Figure 5A, there was increase in NOS2
mRNA expression in spleen already at day 5 day but expression
rose rapidly at day 7 after DENV2 infection of WT mice
(Figure 5A). Evaluation of NOS2 staining in the liver by
immunohistochemistry showed significant NOS2 expression,
virtually only in infiltrating leukocytes, at day 7 after infection
(Figure 5B, C). Consistently with the ability of IFN-c to induce
NOS2, there was no production of NO by dendritic cells infected
with DENV-2, in vitro (Figures 5D). However, treatment of
dendritic cells with IFN-c prior to infection resulted in production
of significant amounts of NO (Figure 5D). In addition, expression
of NOS2 was greatly decreased in spleen of IFN-c
2/2 mice after
DENV-2 infection (Figure 5E). As IL-12 and IL-18 cooperate for
optimal induction of IFN-c (results above), we evaluated whether
treatment of IL-12p40
2/2 mice with IL-18 bp would also results
in reduced NOS2 expression in spleen. As seen in Figure 5E,
concomitant absence of both IL-12 and IL-18 led to impaired
NOS2 expression in spleen that was quantitatively similar to
results obtained in IFN-c
2/2 mice (Figure 5E).
To assess the role played by NOS2-induced NO during DENV
infection, NOS2
2/2 mice were inoculated with DENV-2 and
lethality rates and hematological alterations monitored. As shown
in Figure 6A, NOS2
2/2 mice were markedly susceptible to
DENV infection, as all knockout animals but none of WT mice
were dead by the 10
th day of infection. Thrombocytopenia
(Figures 6B) was more intense earlier but hemoconcentration was
similar in both groups (Figure 6C). There was enhanced splenic
production of TNF-a (Figure 6D) and IL-6 (Figure 6E) and greater
Figure 2. IL-12 controls production of IFN-c and host resistance to DENV infection. (A) WT mice were inoculated with 10LD50 of DENV-2
and at the indicated timepoints, IL-12p70 (left panel) and IL-12p40 (right panel) concentration in spleen were determined by ELISA. (B–K) WT and IL-
12p40
2/2 mice were inoculated with 10LD50 of DENV-2 and at the indicated timepoints, the following parameters were assessed: IFN-c concentration
in spleen (B) and serum (C), measured by ELISA; lethality rates after infection (D); platelet counts (E) and hematocrit (F) in blood; TNF-a (G) and IL-6 (H)
concentration, measured by ELISA, and AST activity (I), measured by colorimetric assay, in serum; Liver injury, assessed by Hematoxylin & Eosin
staining (seven days after infection) (J); Viral loads recovered from the spleen, by plaque assay (K). Results are expressed as mean 6 SEM (except for J,
expressed as median) and are representative of at least two independent experiments. N=6 mice per group. * P,0.05 vs. NI. # P,0.05 vs. WT. NI:
Not infected. ND: Not detected. dpi:day post-infection.
doi:10.1371/journal.pntd.0001449.g002
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NOS2
2/2 than WT mice. Importantly, viral loads in spleen after
DENV-2 infection were significantly greater in NOS2
2/2 than
WT mice (Figures 6H). Of note, all alterations seen in NOS2
2/2-
infected mice were not due to reduction in IFN-c production after
infection. Indeed, IFN-c levels in spleen and serum were similar in
WT and NOS2
2/2 infected mice (Figures 6I and 6J). Therefore,
NOS2-derived NO production is driven by IFN-c and is essential
for host protection during DENV primary infection.
Discussion
The major findings of the present study can be summarized as
follows: 1) IFN-c production is essential for host resistance to
DENV infection. NK and NKT cells are the sources of IFN-c
during the early periods of infection and are followed by CD4
+
and CD8
+ T cells, which are the main producers at the peak of
host response to infection; 2) production of IL-12 and IL-18
precedes IFN-c and optimal IFN-c production relies on the
combined action of IL-12 and IL-18; and 3) IFN-c is essential for
NOS2 induction and NOS2 plays an important role in controlling
virus replication. These studies, therefore, indicate that IL-12/IL-
18-induced IFN-c production and consequent induction of NOS2
are essential for murine host response to DENV infection.
Previous studies support a protective role played by IFN-c
during host response to DENV infection. For example, Shresta
and coworkers have shown that IFN-c receptor-deficient mice
were more susceptible to DENV-induced lethality than WT-
infected mice, despite no differences in viral loads in several target
organs between both groups [17]. The increased susceptibility was
enhanced further when type I IFN receptor was also absent, and
deficiency in both cytokine receptors resulted in disseminated viral
replication [17]. In this respect, IFN receptors-deficient mice
(AG129 strain) are known to be permissive for replication of
DENV clinical isolates in peripheral tissues and CNS, and
represent a well established experimental model of DENV
infection [17–19]. In the present work, we have demonstrated
that IFN-c is produced as early as the fifth day of infection in WT
mice and lack of IFN-c action culminated in early lethality to a
sublethal inoculum. These data establish IFN-c as essential for
Figure 3. IL-18 controls production of IFN-c and host resistance to DENV infection. (A) WT mice were inoculated with 10LD50 of DENV-2
and at the indicated timepoints, IL-18 concentration in liver were determined by ELISA. (B–K) WT and IL-18
2/2 mice were inoculated with 10LD50 of
DENV-2 and at the indicated timepoints, the following parameters were assessed: IFN-c concentration in spleen (B) and serum (C), measured by ELISA;
lethality rates after infection (D); platelet counts (E) and hematocrit (F) in blood; TNF-a (G) and IL-6 (H) concentration in spleen, measured by ELISA;
AST activity in serum (I), measured by colorimetric assay; Liver injury, assessed by Hematoxylin & Eosin staining (seven days after infection) (J); Viral
loads recovered from the spleen, by plaque assay (K). Results are expressed as mean 6 SEM (except for J, expressed as median) and are representative
of at least two independent experiments. N=6 mice per group. * P,0.05 vs. NI. # P,0.05 vs. WT. NI: Not infected. ND: Not detected. dpi:day post-
infection.
doi:10.1371/journal.pntd.0001449.g003
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correlation between increased IFN-c production and higher
survival rates in DHF patients [15] also supports this idea.
Of note, enhanced viral replication in IFN-c-deficient mice was
associated with more severe disease manifestation, as showed by
enhanced hematological alterations and hepatic injury. More
severe disease was also noticed in DENV-infected AG129 mice,
characterized by paralysis and elevated hematocrit [17]. Impor-
tantly, Gunther and colleagues have demonstrated in a human
challenge model of DENV infection that only sustained IFN-c
production was associated with protection against fever and
viremia during the acute phase of illness [31]. These data suggest
that IFN-c is important to prevent worsening of disease. In
humans, epidemiological studies have shown that a substantial
number of patients with severe disease have evidence of a previous
infection with a distinct serotype [1–3,9–11,32]. Several hypotheses
have been raised to explain this immune-mediated enhancement of
disease severity. For example, it has been hypothesized that
subneutralizing levels of antibodies facilitate the entry of viral
particles in permissive cells (a phenomenon termed antibody-
dependent enhancement - ADE), enhancing viral load, and
exacerbating disease manifestation [33]. Experimental DENV
models support this hypothesis and suggest that disease severity is
directly associated with enhanced viral replication during infection
[34,35]. Of note, infected IFN-c-deficient mice, as well as IL-
12p40
2/2 and IL-18
2/2 infected mice, presented elevated viral
loads, in parallel with elevated hematocrits, thrombocytopenia, and
liver injury. Therefore, we may suggest that the worse outcome seen
in mice with reduced IFN-c production after infection is due to
inability in control of DENV replication, leading to viral burden
and enhancement of disease.
Figure 4. IL-12 and IL-18 act in synergism to induce IFN-c
production and resistance to DENV infection. WTandIL-12p40
2/2
mice (n=5 mice per group), treated or not with IL-18 bp (daily i.p.
injection of 250 mg of protein), were inoculated with 10LD50 of DENV-2
(i.p) and, 5 days after infection, The following parameters were assessed:
IFN-c concentration in spleen (A) and serum (B) , measured by ELISA; viral
loads recovered from the spleen, measured by plaque assay (C); platelets
counts (D) and hematocrit (E) in blood; IL-6 concentration in serum,
measured by ELISA (F); Results are expressed as mean 6 SEM (except
for A, expressed as median) and are representative of at least
two independent experiments. N=5 mice per group. * P,0.05 vs. NI.
# P,0.05 vs. WT. NI: Not infected. ND: Not detected.
doi:10.1371/journal.pntd.0001449.g004
Figure 5. IFN-c controls NOS2-mediated NO production during
DENV infection. (A–C) WT mice were inoculated with 10LD50 of DENV-
2 and at the indicated timepoints, the following parameters were
assessed: NOS2 RNA expression in spleen, determined by qPCR (A);
NOS2 staining in liver, assessed by IHC at the 7
th day of infection (B, C).
(D) Bone marrow derived dendritic cells were infected with DENV-2
(MOI 0,1 PFU/cell) in the presence or not of IFN-c, and at the indicated
timepoints, NO production was quantified by Griess reaction. (E). WT,
IFN-c
2/2 and hIL-18 bp-treated IL-12p40
2/2 mice (daily i.p. injection of
250 mg of protein, n=5 mice per group) were inoculated with 10LD50 of
DENV-2 (i.p) and in the fifth day of infection NOS2 RNA expression was
determined by qPCR. Results are shown as fold increase over basal
expression in control mice (A, E); number of positive cells per mm
2 of
liver (B); and mM of nitrite in medium (D). Results are expressed as mean
6 SEM and are representative of at least two independent experiments.
N=5 mice per group. * P,0.05 vs. NI. # P,0.05 vs. WT. In (E), * P,0.05
vs. DENV-2 infected cell, and # for P,0.05 vs. medium or IFN-c-treated
cells. dpi:day post-infection.
doi:10.1371/journal.pntd.0001449.g005
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a significant increase in levels of pro-inflammatory mediators after
DENV infection. Indeed, both TNF-a and IL-6 production were
enhanced in DENV-2 infected IFN-c
2/2, IL-12p40
2/2, and IL-
18
2/2 mice, when compared with WT controls. Increased levels
of these cytokines have been associated with severity of dengue
manifestation in humans [36–38]. Hence, enhanced TNF-a
release by T cells during secondary stimulation with DENV
antigens was found in hospitalized patients with more severe
disease evolution [39]. In addition, the ratio of TNF-a-producing
to IFN-c-producing T cells among peripheral blood mononuclear
cells from dengue-vaccine recipients was shown to be greater after
in vitro stimulation with antigen from heterologous dengue
serotypes [39], suggesting that increased amounts of TNF-a alters
response to infection and may result in more-severe disease
manifestation. Findings in murine experimental models support
this idea [40]. Altogether, these findings in humans suggest that
IFN-c production is associated with protective responses to DENV
infection and that severe disease may occur due to absence of
proper IFN-c release and to enhanced TNF-a production during
response, although it remains to be shown if enhanced TNF-a
production seen in DENV infected IFN-c
2/2 mice was due to T
cells or to any other cellular population.
Interestingly, enhanced viral load have also been associated
with increased pro-inflammatory response during mouse exper-
imental infection by West Nile virus [41], another important
flavivirus that is pathogenic to humans. The latter findings
support the hypothesis that increased virus replication in the
absence of IFN-c production leads to increased pro-inflamma-
tory mediators response. TNF-a blockade in experimental
models of DENV infection resulted in prevention of disease
[19,23] and TNF-a action has been implicated in increased
vascular permeability after infection in experimental settings
[13]. Of note, inhibition of other pro-inflammatory mediators
produced in the evaluated experimental model of DENV
infection, including PAF and MIF, is associated with reduced
production of TNF-a and IL-6 and milder disease manifestation,
reduced hypotension and vascular permeability after DENV
infection [13,24,25]. Hepatic injury was also enhanced in IFN-
c
2/2 mice infected with DENV. Data from our laboratory
suggest that enhanced liver injury during experimental DENV
infection involves both productive viral infection of hepatocytes
and immunopathological mechanisms, such as enhanced leuko-
cyte arrest and activation in hepatic tissue (our unpublished data,
manuscript in preparation). Therefore, the elevation of pro-
inflammatory cytokine production and consequent liver injury
Figure 6. NOS2-deficient mice are more susceptible to DENV infection. WT and NOS2
2/2 mice were inoculated with 10LD50 of DENV-2 and
at the indicated timepoints, the following parameters were assessed: lethality rates after infection (A); platelet counts (B) and hematocrit (C) in blood;
TNF-a (D) and IL-6 (E) concentration in spleen, measured by ELISA; AST activity in serum (F), measured by colorimetric assay; Liver injury, assessed by
Hematoxylin & Eosin staining (seven days after infection) (G); Viral loads recovered from the spleen, by plaque assay (H). IFN-c concentration in spleen
(I) and serum (J) measured by ELISA; Results are expressed as mean 6 SEM (except for H, expressed as median) and are representative of at least two
independent experiments. N=6 mice per group. * P,0.05 vs. NI. # P,0.05 vs. WT. NI: Not infected. ND: Not detected. dpi:day post-infection.
doi:10.1371/journal.pntd.0001449.g006
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outcome after DENV infection in mice.
Several studies have demonstrated the IFN-c-inductive role
played by IL-12 and IL-18 during experimental models of viral
infections [20,21,42]. Here, we have shown that IL-12 and IL-18
were produced early after DENV infection. The kinetics of
production of these cytokines was compatible with their inductive
role of IFN-c production. In support of the latter possibility, IL-
12p40
2/2 and IL-18
2/2 mice presented marked reduction in
IFN-c production after DENV infection. In addition, absence of
one of these cytokines led to worsening of dengue disease, despite a
small delay in peak of DENV-induced alterations. Of note, only
during simultaneous blockade of both IL-12 and IL-18, there was
complete abrogation of IFN-c production. Interestingly, IL-12
2/2
mice treated with IL-18 bp presented marked enhancement of
splenic viral loads already at the 5
th day post DENV-2 infection
and disease seen in these mice was very similar to that found in
infected IFN-c
2/2 mice. Thus, IL-12 and IL-18 act synergistically
to induce IFN-c production during DENV infection. Of note, IL-
18 production has been shown to be dependent on inflammasome
complex activation [43], suggesting that this molecular scaffold
may play a role in the control of IFN-c production and in host
resistance to DENV infection.
IL-18 is known to augment IL-12-induced IFN-c production by
T and NK cells [20,21,42,44], and absence of IFN-c in infected
mice is known to abolish both NK cell and CTL responses during
viral infections [42,44]. Our data suggest that, upon infection, NK
and NKT cells are the cell populations involved in early IFN-c
production and that CD8
+ and CD4
+ T cells are the main IFN-c
producers at later moments of response to infection (7
th day). IFN-
c production by CD4
+ T cells during experimental DENV
infection has been previously demonstrated [45]. In addition, CD8
T cell activation has been associated to protection to DENV
primary infection in mice [46,47]. Our data showing a significant
increase in IFN-c
+ NK and NKT cells and the finding that IFN-
c
2/2 mice succumb very early to infection suggest a important
role for these cell populations in mediating resistance to DENV
infection during its initial phases. Of note, NK cell activation early
after experimental DENV infection has been previously demon-
strated [44]. Interestingly, increased percentages of NK cells and
of activated NK cells were also associated with milder DF, whereas
reduced cell counts, low percentages and lack of activation
markers (comparable to healthy controls) were associated with
evolution to DHF in patients [48,49]. Altogether, these observa-
tions suggest that sequential and coordinated IFN-c production by
these lymphocytes populations during DENV infection is an event
of extreme importance for host resistance to disease.
However, it remains to be shown the antigenic specificity of
these IFN-c-producing lymphocytes in the studied experimental
settings. In addition, whether these cells are poly-functional and
secrete other cytokines or present other effector functions remain
to be studied. In this regard, it has been demonstrated that
development of subclinical secondary infection in school children
is associated with increased proportions of DENV-specific TNF-a,
IFN-c and IL-2-producing CD4
+ and CD8
+ T cells [50],
suggesting that poly-functional responses correlate with protection
to severe disease manifestation. On the contrary, cytokine-
producing T cells (especially TNF-a and/or IFN-c) were
associated with DHF development in patients and these DHF
associated, cytokine-producing T cells were shown to be negative
for CD107a staining, suggesting that these lymphocyte populations
represent mono-functional or oligo-functional T cells [51].
Therefore, assessment of the pattern of T cell cytokine production
and of the mechanisms controlling such polyfunctionality (whether
IL-12 and or IL-18 are involved in such control) may provide
important information regarding protective versus pathogenic
responses to DENV infection and may bear relevance during
development of vaccinal strategies. At the moment, these subjects
have been matter of ongoing analysis in our experimental infection
model.
Apart from promotion of NK and CTL responses, IFN-c seems
to be important for viral clearance by induction of NO production.
It has been shown that NOS2 expression is increased upon DENV
infection in humans and that this expression in peripheral blood
monocytes of DF patients was found to correlate with the late
acute phase of disease and preceded the clearance of DENV from
monocytes [52]. Hence, NO production was associated with less
severe form of dengue disease in humans [53]. Here, we
demonstrate that NOS2 expression is increased during DENV
infection and that this expression is controlled by IFN-c
production, once IFN-c
2/2 and IL-12p40
2/2 mice treated with
IL-18 bp presented reduced NOS2 expression. In addition, IFN-c
stimulation was necessary for NO production by DENV-infected
DCs, in vitro. Importantly, blockade of NOS2 action was associated
with enhanced viral loads after infection, and more severe disease
manifestation, even in the presence of high levels of IFN-c.O f
note, NO is able to inhibit DENV replication in human cells in vitro
[54,55], an effect associated with inhibition of DENV associated
polymerase activity [54–56]. Thus, NOS2-mediated NO produc-
tion is pivotal for resistance to DENV infection and this seems to
be a major pathway involved in IFN-c-mediated resistance to
disease. However, in the absence of NOS2, animals die with a
slower kinetics than IFN-c
2/2 mice, suggesting that mechanisms
in addition to NOS2-mediated NO production may be relevant
for IFN-c-mediated host protection to infection. This could
involve the presence of CTL responses and NK cells, but not
NKT cells, which seem to play detrimental role in experimental
DENV infection [57]. These IFN-c-dependent and NOS2-
independent mechanisms are currently being investigated in our
laboratory.
However, other studies have demonstrated a pathogenic role for
NO during DENV infection. Utilizing human cell lines and
experimental mouse infection, it has been shown that overproduc-
tion of NO could lead to endothelial cell damage, and cross-reactive
antibodies against endothelial cells, present during DENV infection,
were found to induce cell damage in an NO-dependent manner
[58]. For example, Yen and coworkers have found that tissue
hemorrhage after experimental DENV infection was dependent
upon reactive nitrogen species production by endothelial cells. This
eventwasassociatedwithincreasedendothelialcellapoptosisduring
infection [59]. Although NOS2 inhibition resulted in reduced
hemorrhage, viral replication was not evaluated. In addition, the
increased hemorrhage displayed after NO production seemed to be
an endothelial cell-associated phenomenon and was potentiated by
TNF-a and reactive oxygen species (ROS). On the contrary, IFN-c-
mediated NO inhibition of viral replication was demonstrated
especially in leukocytes population both in human and mouse
settings [52–56]. Our results showed that NOS2 staining during
DENV-2 infection in the present model was mainly associated to
leukocytes. These findings suggest that NO may have a dual role
during DENV infection and that this is associated with the cell
populations involved in NO production and on the presence of
additional inflammatory mediators. NO production by infected
leukocytes may be associated to control of viral replication and
prevention of disease evolution, while NO production by endothe-
lial cells, especially in the presence of TNF-a and ROS, would favor
cell death and more severe disease manifestation. Additional
experiments evaluating cell-specific NOS2-deficient mice will help
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NO in the context of experimental dengue.
In conclusion, we have demonstrated that IFN-c production is
essential for host resistance to DENV infection. IFN-c production
upon infection is controlled by concomitant production of IL-12
and IL-18 and the IFN-c-dependent mechanisms associated to
resistance to dengue disease involve NOS2 up-regulation and
consequent NO production. In the absence of these molecules,
there is enhancement of viral burden and more severe manifes-
tation of dengue disease. Thus, IFN-c induction helps to
orchestrate immune response maturation, control of viral
replication and regulation of inflammatory response during host
response to DENV infection, defining the outcome of dengue
disease. Despite extrapolation of this experimental scenario to
human infection requires further investigation, we may suggest
that strategies that improve the production of IFN-c-mediated
immunity by the host could be useful during the control of primary
infection by Dengue virus.
Supporting Information
Figure S1 Gating strategy utilized for analysis and
representative histograms of IFN-c production after
DENV-2 infection. WT mice were inoculated with 10LD50 of
DENV-2 and at the indicated timepoints, IFN-c intracellular
staining in splenic cells was assessed by FACS analysis utilizing the
following gating strategy (A) Lymphocyte/monocyte population
was isolated among total events as the region R1. 50,000 events at
R1 were collected for analysis (left panel). At this region, the cell
population positive for IFN-c staining defined as total IFN-c
+-cells
(middle panel - R2). Right panel A contains representative
histograms of total IFN-c
+-cells in each group analyzed. (B) At
region R1 in panel A, CD4
+ cells were isolated (R3 in left panel B),
and the cell population positive for IFN-c staining among them,
defined as CD4
+ IFN-c
+-cells (middle panel B - R4). Right panel B
contains representative histograms of CD4
+ IFN-c
+-cells in each
group analyzed. (C) At region R1 in panel A, CD8
+ cells were
isolated (R5 in left panel C), and the cell population positive for
IFN-c staining among them, defined as CD8
+ IFN-c
+-cells (middle
panel C – R6). Right panel C contains representative histograms
of CD8
+ IFN-c
+-cells in each group analyzed. (D) At region R1 in
panel A, cells were sorted by their staining for CD3 and NK1.1
(left upper panel D). CD3
+ NK1.1
+ cells were isolated (R7 at the
upper left panel D), and the cell population positive for IFN-c
staining among them, defined as CD3
+ NK1.1
+ IFN-c
+-cells
(upper middle panel D – R9). Upper right panel D contains
representative histograms of CD3
+ NK1.1
+ IFN-c
+-cells. CD3
2
NK1.1
+ cells were isolated (R8 at the upper left panel D), and the
cell population positive for IFN-c staining among them, defined as
CD3
2 NK1.1
+ IFN-c
+-cells (bottom left panel D - R10). Bottom
middle panel D contains representative histograms of CD3
2
NK1.1
+ IFN-c
+-cells. Groups analyzed were Not infected animals
(dotted line), animals in the 5
th day post infection (dashed lines)
and animals at the 7
th day post infection (continuous line). Grey
filled histograms represent Isotype-stained cells. NI: Not infected.
dpi: days post-infection.
(TIF)
Figure S2 IL-23 does not participate in IFN-c-mediated
resistance to DENV infection. (A–D) WT and IL-23p19
2/2
mice were inoculated with 10LD50 of DENV-2 and at the seventh
day of infection, the following parameters were assessed: IFN-c
concentration in serum (A), measured by ELISA; platelet counts
(B) and hematocrit (C) in blood; Viral loads recovered from the
spleen, by plaque assay (D). Results are expressed as mean 6 SEM
(except for D, expressed as median) and are representative of at
least two independent experiments. N=4 mice per group.
*P ,0.05 vs. NI. # P,0.05 vs. WT. NI: Not infected. ND: Not
detected.
(TIF)
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